Jingwei Yu

3.6k total citations
69 papers, 990 citations indexed

About

Jingwei Yu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Jingwei Yu has authored 69 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Pathology and Forensic Medicine and 18 papers in Oncology. Recurrent topics in Jingwei Yu's work include Lymphoma Diagnosis and Treatment (13 papers), Genomic variations and chromosomal abnormalities (12 papers) and Immune Cell Function and Interaction (6 papers). Jingwei Yu is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Genomic variations and chromosomal abnormalities (12 papers) and Immune Cell Function and Interaction (6 papers). Jingwei Yu collaborates with scholars based in China, United States and Sweden. Jingwei Yu's co-authors include B. Belinda Ding, Giorgio Cattoretti, Lourdes Mendez, Rita Shaknovich, Raymond Yu, Yonghui Zhang, Jing Gao, Lin Shen, Fa‐Ten Kao and Teresa L. Yang‐Feng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Nano Letters.

In The Last Decade

Jingwei Yu

64 papers receiving 973 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingwei Yu China 18 349 280 241 166 127 69 990
Jiaohong Wang United States 25 759 2.2× 196 0.7× 122 0.5× 128 0.8× 82 0.6× 36 2.0k
Alessandro Gulino Italy 21 396 1.1× 288 1.0× 98 0.4× 425 2.6× 52 0.4× 53 1.3k
Ying‐Cheng Chiang Taiwan 23 529 1.5× 552 2.0× 163 0.7× 342 2.1× 80 0.6× 85 1.8k
Miki Nishimura Japan 18 422 1.2× 264 0.9× 85 0.4× 122 0.7× 76 0.6× 49 1.1k
Ké Li China 22 785 2.2× 357 1.3× 90 0.4× 228 1.4× 64 0.5× 96 1.5k
Bing Tu China 18 429 1.2× 357 1.3× 70 0.3× 141 0.8× 63 0.5× 46 1.2k
Julia A. Ju United States 14 463 1.3× 364 1.3× 86 0.4× 101 0.6× 79 0.6× 24 1.0k
Toshinori Ando Japan 16 428 1.2× 293 1.0× 81 0.3× 85 0.5× 33 0.3× 56 962

Countries citing papers authored by Jingwei Yu

Since Specialization
Citations

This map shows the geographic impact of Jingwei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingwei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingwei Yu more than expected).

Fields of papers citing papers by Jingwei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingwei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingwei Yu. The network helps show where Jingwei Yu may publish in the future.

Co-authorship network of co-authors of Jingwei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingwei Yu. A scholar is included among the top collaborators of Jingwei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingwei Yu. Jingwei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yu, Jingwei, et al.. (2025). CMOEP regimen in the treatment of untreated peripheral T-cell lymphoma: a multicenter, single-arm, phase I study. Frontiers in Immunology. 16. 1551723–1551723. 1 indexed citations
3.
4.
Gao, Lei, Haolan Tao, Li Gong, et al.. (2025). Partially Amorphous Pearl-Chain-Shaped PtTe Nanowires for Robust Fuel Cell Catalysis. Nano Letters. 25(21). 8732–8739. 3 indexed citations
5.
Yu, Jingwei, Xiaorong Zhong, Lijuan Jiang, et al.. (2025). Carbon‐Encapsulated PtCo Intermetallic/Co‐N‐C Hybrid Catalyst for Ultralow‐Pt‐Loading Fuel‐Cell Catalysis. Advanced Energy Materials. 16(6).
6.
Yu, Jingwei, Yan Sun, Tingting Liu, et al.. (2024). 651P Phase I study of XNW27011, a novel claudin 18.2 ADC, in patients with locally advanced and/or metastatic solid tumors. Annals of Oncology. 35. S514–S514. 3 indexed citations
7.
8.
Levy, Brynn, M. Anwar Iqbal, Barbara R. DuPont, et al.. (2024). Multisite Evaluation and Validation of Optical Genome Mapping for Prenatal Genetic Testing. Journal of Molecular Diagnostics. 26(10). 906–916. 5 indexed citations
9.
Lü, Ke, Zheng Song, Jingwei Yu, et al.. (2024). Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers. European Journal of Cancer. 213. 115069–115069. 3 indexed citations
10.
Fu, Yanhong, Pengpeng Xie, Qingping Yang, Peng Chen, & Jingwei Yu. (2023). Analysis on the therapeutic effect of Cangfu Daotan Decoction combined with drospirenone and ethinylestradiol tablets (II) on patients with polycystic ovary syndrome. Prostaglandins & Other Lipid Mediators. 170. 106801–106801.
11.
Arias, Jonathan, Jingwei Yu, Mukesh Varshney, José Inzunza, & Ivan Nalvarte. (2021). Hematopoietic Stem Cell- and Induced Pluripotent Stem Cell-Derived CAR-NK Cells as Reliable Cell-Based Therapy Solutions. Stem Cells Translational Medicine. 10(7). 987–995. 39 indexed citations
12.
Lang, Mingxiao, Jingwei Yu, Xianhuo Wang, et al.. (2018). Immunochemotherapeutic increase of peripheral absolute monocyte count predicts interstitial pneumonia in lymphoma patients. Hematological Oncology. 36(5). 779–785. 3 indexed citations
13.
Yu, Jingwei, Boris Bartholdy, Zijun Y. Xu‐Monette, et al.. (2016). An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL. Blood. 128(24). 2797–2807. 48 indexed citations
14.
Li, Yang, Jingwei Yu, Ming Lü, et al.. (2014). Change of Body Weight and Macrophage Inhibitory Cytokine-1 during Chemotherapy in Advanced Gastric Cancer: What Is Their Clinical Significance?. PLoS ONE. 9(2). e88553–e88553. 36 indexed citations
15.
Yu, Jingwei, Jing Gao, Zhihao Lü, Yilin Li, & Lin Shen. (2012). Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine. Medical Oncology. 29(5). 3029–3034. 21 indexed citations
16.
Qi, Zhongxia, Gary S. Hoffman, Daniel Kurtycz, & Jingwei Yu. (2003). Prevalence of the C677T substitution of the methylenetetrahydrofolate reductase (MTHFR) gene in Wisconsin. Genetics in Medicine. 5(6). 458–459. 12 indexed citations
17.
Reeves, Roger H., et al.. (1998). StchMaps to Mouse Chromosome 16, Extending the Conserved Synteny with Human Chromosome 21. Genomics. 49(1). 156–157. 9 indexed citations
18.
Yu, Jingwei, et al.. (1995). YAC contig mapping of six expressed sequences encoded by human chromosome 21. Somatic Cell and Molecular Genetics. 21(2). 133–137. 4 indexed citations
19.
20.
Yang‐Feng, Teresa L., Keqin Zheng, Jingwei Yu, et al.. (1992). Assignment of the human glycogen debrancher gene to chromosome 1p21. Genomics. 13(4). 931–934. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiaohong Wang Breakdown of academic impact, for papers by Alessandro Gulino Breakdown of academic impact, for papers by Ying‐Cheng Chiang Breakdown of academic impact, for papers by Miki Nishimura Breakdown of academic impact, for papers by Ké Li Breakdown of academic impact, for papers by Bing Tu Breakdown of academic impact, for papers by Julia A. Ju Breakdown of academic impact, for papers by Toshinori Ando
Rankless by CCL
2026